Task: Answer the multiple choice question.
Query: Which drug exhibits a -17.495\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] CC(=O)NC(CCS(C)(=O)=O)C(=O)Nc1ccc(F)cc1Cl
[b] CCC(C)NC(=O)CCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
Answer: b. CCC(C)NC(=O)CCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)NC(=O)CCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
CCC(C)NC(=O)CCNS(=O)(=O)c1ccc2c(c1)oc(=O)n2C
N-butan-2-yl-3-[(3-methyl-2-oxo-1,3-benzoxazol-6-yl)sulfonylamino]propanamide